Announce Date | 03/06/2025 |
EPS Normalized Actual | $1.6 (Beat by $0.09) |
EPS GAAP Actual | $1.6 (Beat by $0.09) |
Revenue Actual | $14.916B |
Revenue Surprise | Beat by $14916M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Nov 2028 | 0 | INF | 0 | 0 | 1 |
Oct 2028 | 0 | INF | 0 | 0 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Feb 2025) | 1.17 | 1.17 | 14.916B | 19.81% | 14916M |
FQ4 2024 (Nov 2024) | 0.92 | 0.92 | 14.054B | 33.86% | 14054M |
FQ3 2024 (Aug 2024) | -0.4 | -0.4 | 13.072B | 32.1% | 13072M |
FQ2 2024 (May 2024) | 4.56 | 4.56 | 12.487B | 100% | 12487M |
FQ1 2024 (Feb 2024) | 2.84 | 2.84 | 11.961B | 25.47% | 11961M |
FQ4 2023 (Oct 2023) | 8.53 | 8.53 | 9.295B | 3.93% | 9295M |
FQ3 2023 (Jul 2023) | 8 | 8 | 8.876B | 4.64% | 8876M |
FQ1 2023 (Mar 2023) | 9.03 | 9.03 | 8.915B | 100% | 8915M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Nov 2027) | 2.48643 | -- | 2.47243 | 2.58006 | 28 |
FQ3 2027 (Aug 2027) | 2.34541 | -- | 2.3322 | 2.43373 | 16 |
FQ2 2027 (May 2027) | 2.23241 | -- | 2.21984 | 2.31648 | 15 |
FQ1 2027 (Feb 2027) | 2.21279 | -- | 2.20269 | 2.26098 | 11 |
FQ4 2026 (Nov 2026) | 2.11467 | -- | 2.10501 | 2.16072 | 6 |
FQ3 2026 (Aug 2026) | 1.98109 | -- | 1.97204 | 2.02423 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Nov 2027) | 22.75B | -- | 22.65B | 23.41B | 15 |
FQ3 2027 (Aug 2027) | 21.48B | -- | 21.39B | 22.11B | 25 |
FQ2 2027 (May 2027) | 20.66B | -- | 20.57B | 21.25B | 15 |
FQ1 2027 (Feb 2027) | 20.09B | -- | 20.02B | 20.43B | 10 |
FQ4 2026 (Nov 2026) | 19.31B | -- | 19.24B | 19.63B | 14 |
FQ3 2026 (Aug 2026) | 18.26B | -- | 18.2B | 18.57B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Feb 2025) | 1.17 | 1.17 | 100% | |
FQ4 2024 (Nov 2024) | 0.92 | 0.92 | 100% | |
FQ3 2024 (Aug 2024) | -0.4 | -0.4 | 100% | |
FQ2 2024 (May 2024) | 4.56 | 4.56 | 100% | |
FQ1 2024 (Feb 2024) | 2.84 | 2.84 | 100% | |
FQ4 2023 (Oct 2023) | 8.53 | 8.53 | 100% | |
FQ3 2023 (Jul 2023) | 8 | 8 | 100% | |
FQ1 2023 (Mar 2023) | 9.03 | 9.03 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Feb 2025) | $0B | $14.92B | $14916M | 100% |
FQ4 2024 (Nov 2024) | $0B | $14.05B | $14054M | 100% |
FQ3 2024 (Aug 2024) | $0B | $13.07B | $13072M | 100% |
FQ2 2024 (May 2024) | $0B | $12.49B | $12487M | 100% |
FQ1 2024 (Feb 2024) | $0B | $11.96B | $11961M | 100% |
FQ4 2023 (Oct 2023) | $0B | $9.3B | $9295M | 100% |
FQ3 2023 (Jul 2023) | $0B | $8.88B | $8876M | 100% |
FQ1 2023 (Mar 2023) | $0B | $8.92B | $8915M | 100% |